Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD, amitriptyline and tramadol drug-drug interaction study
2023-508428-36-00Phase 2Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cannabidiol, amitriptyline and tramadol, sponsored by Centre for Human Drug Research. Primary endpoint: Pharmacokinetic interaction between cannabidiol, amitriptyline, and tramadol. Started Dec 2023; status: completed.
02
Drugs
cannabidiolamitriptylinetramadol
Beyond the preview
Go deeper on 2023-508428-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508428-36-00.